Paras Healthcare Limited
PARASHLTH · NSE · ₹936 a share (close of 13 Nov 2026)
Available company data, source links and archived checks for Paras Healthcare Limited. Read each source and date: a past check is not a fresh review, and some earlier figures have incomplete source details.
Net profit was ₹40.4 crore.
Quarter ended 2026-09-30 · consolidated · Company filing
Recorded quarterly figures
| Quarter | Revenue / income | YoY |
Profit | YoY | Net margin | Source |
|---|
| Sep 2026 | Revenue: ₹511 cr | — | Net profit: ₹40 cr | — | 7.9% | Company filing source |
YoY means change from the same quarter a year earlier.
— means no comparable figure is available. Older entries with incomplete source
details have not been revalidated under the current checks.
Filing timeline — what the company told the exchange
- Analysts/Institutional Investor Meet/Con. Call Updates. Paras Healthcare Limited has informed the Exchange about Schedule of meet
Company disclosure · 12 Nov 2026 · document
- Analysts/Institutional Investor Meet/Con. Call Updates. Paras Healthcare Limited has informed the Exchange about Link of Recording
Company disclosure · 06 Nov 2026 · document
- Paras Healthcare Limited has informed the Exchange about Copy of Newspaper Publication
Company disclosure · 06 Nov 2026 · document
- Paras Healthcare Limited has informed the Exchange about Investor Presentation
Company disclosure · 06 Nov 2026 · document
- Paras Healthcare Limited has informed the Exchange regarding Change in Director(s) of the company.
Company disclosure · 05 Nov 2026 · document
- Press Release. Paras Healthcare Limited has informed the Exchange regarding a press release dated November 05, 2026, titled "Paras Health reports robust revenue
Company disclosure · 05 Nov 2026 · document
- Outcome of Board Meeting. Paras Healthcare Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
Company disclosure · 05 Nov 2026 · document
- Analysts/Institutional Investor Meet/Con. Call Updates. Paras Healthcare Limited has informed the Exchange about Schedule of meet
Company disclosure · 03 Nov 2026 · document
Follow this company without reading every document yourself.
Keep its available filings, dated fact checks and disclosure alerts together.
Your saved country sets your market and its research schedule.
Start free — first week on us →
India ₹149/month · Rest of world US$4.99/month after the free trial · research, not investment
advice · cancel any time